Hmdb loader
Record Information
Version5.0
StatusDetected but not Quantified
Creation Date2021-09-11 09:26:06 UTC
Update Date2021-09-26 23:04:03 UTC
HMDB IDHMDB0251810
Secondary Accession NumbersNone
Metabolite Identification
Common NameEniluracil
DescriptionEniluracil belongs to the class of organic compounds known as pyrimidones. Pyrimidones are compounds that contain a pyrimidine ring, which bears a ketone. Pyrimidine is a 6-membered ring consisting of four carbon atoms and two nitrogen centers at the 1- and 3- ring positions. Normally, 5-FU is rapidly broken down in the body by an enzyme known as dihydropyrimidine dehydrogenase (DPD). Eniluracil is a drug which is used for the treatment of cancer in combination with 5-fluorouracil. Eniluracil irreversibly inhibits DPD, thereby substantially slowing the breakdown of 5-FU and prolonging exposure of the tumor cells to the drug. Eniluracil is an orally active dihydropyrimidine dehydrogenase (DPD) inhibitor, designed to enhance activity of chemotaxic agents. Eniluracil is an extremely weak basic (essentially neutral) compound (based on its pKa). Eniluracil has received Orphan Drug status from the FDA for the treatment of hepatocellular cancer in combination with fluoropyrimidines (including 5-FU). Eniluracil, which was previously under development by GlaxoSmithKline (GSK), is being developed by Adherex to enhance the therapeutic value and effectiveness of 5-fluorouracil (5-FU), one of the world’s most widely-used oncology agents. 5-FU is widely used in the U.S. and is often first or second line therapy for a variety of cancers including colorectal, breast, gastric, head and neck, ovarian and basal cell cancer of the skin. It is under investigation by Adherex, under license from GlaxoSmithKline, for the treatment of cancer in combination with 5-fluorouracil (5-FU). Eniluracil could improve 5-FU by increasing its effectiveness, reducing its side effects and/or making it orally available. This compound has been identified in human blood as reported by (PMID: 31557052 ). Eniluracil is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Eniluracil is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources.
Structure
Thumb
Synonyms
ValueSource
776c85ChEMBL
5-EthynyluracilMeSH
Compound 776CMeSH
Chemical FormulaC6H4N2O2
Average Molecular Weight136.1082
Monoisotopic Molecular Weight136.027277382
IUPAC Name5-ethynyl-1,2,3,4-tetrahydropyrimidine-2,4-dione
Traditional Name5-ethynyluracil
CAS Registry NumberNot Available
SMILES
O=C1NC=C(C#C)C(=O)N1
InChI Identifier
InChI=1S/C6H4N2O2/c1-2-4-3-7-6(10)8-5(4)9/h1,3H,(H2,7,8,9,10)
InChI KeyJOZGNYDSEBIJDH-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as pyrimidones. Pyrimidones are compounds that contain a pyrimidine ring, which bears a ketone. Pyrimidine is a 6-membered ring consisting of four carbon atoms and two nitrogen centers at the 1- and 3- ring positions.
KingdomOrganic compounds
Super ClassOrganoheterocyclic compounds
ClassDiazines
Sub ClassPyrimidines and pyrimidine derivatives
Direct ParentPyrimidones
Alternative Parents
Substituents
  • Pyrimidone
  • Hydropyrimidine
  • Vinylogous amide
  • Heteroaromatic compound
  • Lactam
  • Urea
  • Acetylide
  • Azacycle
  • Organic oxide
  • Organopnictogen compound
  • Organooxygen compound
  • Organonitrogen compound
  • Organic oxygen compound
  • Organic nitrogen compound
  • Hydrocarbon derivative
  • Aromatic heteromonocyclic compound
Molecular FrameworkAromatic heteromonocyclic compounds
External DescriptorsNot Available
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
logP-0.91ALOGPS
logP-0.82ChemAxon
logS-2.7ALOGPS
pKa (Strongest Acidic)9.5ChemAxon
pKa (Strongest Basic)-6.4ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count2ChemAxon
Hydrogen Donor Count2ChemAxon
Polar Surface Area58.2 ŲChemAxon
Rotatable Bond Count0ChemAxon
Refractivity33.39 m³·mol⁻¹ChemAxon
Polarizability12.05 ųChemAxon
Number of Rings1ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DeepCCS[M+H]+127.05330932474
DeepCCS[M-H]-124.1730932474
DeepCCS[M-2H]-161.0830932474
DeepCCS[M+Na]+135.90430932474
AllCCS[M+H]+127.232859911
AllCCS[M+H-H2O]+122.532859911
AllCCS[M+NH4]+131.632859911
AllCCS[M+Na]+132.932859911
AllCCS[M-H]-123.332859911
AllCCS[M+Na-2H]-124.932859911
AllCCS[M+HCOO]-126.732859911

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
EniluracilO=C1NC=C(C#C)C(=O)N12187.0Standard polar33892256
EniluracilO=C1NC=C(C#C)C(=O)N11434.3Standard non polar33892256
EniluracilO=C1NC=C(C#C)C(=O)N11825.3Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
Eniluracil,1TMS,isomer #1C#CC1=CN([Si](C)(C)C)C(=O)[NH]C1=O1679.1Semi standard non polar33892256
Eniluracil,1TMS,isomer #1C#CC1=CN([Si](C)(C)C)C(=O)[NH]C1=O1567.7Standard non polar33892256
Eniluracil,1TMS,isomer #1C#CC1=CN([Si](C)(C)C)C(=O)[NH]C1=O2267.0Standard polar33892256
Eniluracil,1TMS,isomer #2C#CC1=C[NH]C(=O)N([Si](C)(C)C)C1=O1618.5Semi standard non polar33892256
Eniluracil,1TMS,isomer #2C#CC1=C[NH]C(=O)N([Si](C)(C)C)C1=O1569.2Standard non polar33892256
Eniluracil,1TMS,isomer #2C#CC1=C[NH]C(=O)N([Si](C)(C)C)C1=O2230.0Standard polar33892256
Eniluracil,2TMS,isomer #1C#CC1=CN([Si](C)(C)C)C(=O)N([Si](C)(C)C)C1=O1814.1Semi standard non polar33892256
Eniluracil,2TMS,isomer #1C#CC1=CN([Si](C)(C)C)C(=O)N([Si](C)(C)C)C1=O1722.5Standard non polar33892256
Eniluracil,2TMS,isomer #1C#CC1=CN([Si](C)(C)C)C(=O)N([Si](C)(C)C)C1=O2059.9Standard polar33892256
Eniluracil,1TBDMS,isomer #1C#CC1=CN([Si](C)(C)C(C)(C)C)C(=O)[NH]C1=O1923.8Semi standard non polar33892256
Eniluracil,1TBDMS,isomer #1C#CC1=CN([Si](C)(C)C(C)(C)C)C(=O)[NH]C1=O1808.5Standard non polar33892256
Eniluracil,1TBDMS,isomer #1C#CC1=CN([Si](C)(C)C(C)(C)C)C(=O)[NH]C1=O2357.1Standard polar33892256
Eniluracil,1TBDMS,isomer #2C#CC1=C[NH]C(=O)N([Si](C)(C)C(C)(C)C)C1=O1825.8Semi standard non polar33892256
Eniluracil,1TBDMS,isomer #2C#CC1=C[NH]C(=O)N([Si](C)(C)C(C)(C)C)C1=O1808.0Standard non polar33892256
Eniluracil,1TBDMS,isomer #2C#CC1=C[NH]C(=O)N([Si](C)(C)C(C)(C)C)C1=O2309.2Standard polar33892256
Eniluracil,2TBDMS,isomer #1C#CC1=CN([Si](C)(C)C(C)(C)C)C(=O)N([Si](C)(C)C(C)(C)C)C1=O2129.0Semi standard non polar33892256
Eniluracil,2TBDMS,isomer #1C#CC1=CN([Si](C)(C)C(C)(C)C)C(=O)N([Si](C)(C)C(C)(C)C)C1=O2154.3Standard non polar33892256
Eniluracil,2TBDMS,isomer #1C#CC1=CN([Si](C)(C)C(C)(C)C)C(=O)N([Si](C)(C)C(C)(C)C)C1=O2224.1Standard polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - Eniluracil GC-MS (Non-derivatized) - 70eV, Positivesplash10-000i-8900000000-dd78f7511ef0363019ea2017-08-28Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Eniluracil GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Eniluracil 10V, Positive-QTOFsplash10-000i-0900000000-91f69a9c7425d66542542017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Eniluracil 20V, Positive-QTOFsplash10-00ko-9400000000-eb40a8fc8f91fb98cccf2017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Eniluracil 40V, Positive-QTOFsplash10-00kf-9000000000-16a33dacd870a54266ce2017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Eniluracil 10V, Negative-QTOFsplash10-000l-7900000000-59cd76042099a05be4182017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Eniluracil 20V, Negative-QTOFsplash10-0006-9000000000-21295633deb9b38ed3e32017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Eniluracil 40V, Negative-QTOFsplash10-0006-9000000000-46955e1a964154bcde692017-07-26Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Eniluracil 10V, Positive-QTOFsplash10-000i-1900000000-8262de422e825bf6ae452021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Eniluracil 20V, Positive-QTOFsplash10-00kv-9200000000-0cc027a8755e27b7cac82021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Eniluracil 40V, Positive-QTOFsplash10-0002-9000000000-8246c659a113d53d4d1d2021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Eniluracil 10V, Negative-QTOFsplash10-000i-5900000000-520ed84c90966de174a52021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Eniluracil 20V, Negative-QTOFsplash10-0006-9000000000-c0461c2f89ca9cb548ae2021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Eniluracil 40V, Negative-QTOFsplash10-0006-9000000000-fd5b628f5d050c1010422021-10-12Wishart LabView Spectrum

NMR Spectra

Spectrum TypeDescriptionDeposition DateSourceView
Predicted 1D NMR13C NMR Spectrum (1D, 100 MHz, D2O, predicted)2021-10-13Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 100 MHz, D2O, predicted)2021-10-13Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 1000 MHz, D2O, predicted)2021-10-13Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 1000 MHz, D2O, predicted)2021-10-13Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 200 MHz, D2O, predicted)2021-10-13Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 200 MHz, D2O, predicted)2021-10-13Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 300 MHz, D2O, predicted)2021-10-13Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 300 MHz, D2O, predicted)2021-10-13Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 400 MHz, D2O, predicted)2021-10-13Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 400 MHz, D2O, predicted)2021-10-13Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 500 MHz, D2O, predicted)2021-10-13Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 500 MHz, D2O, predicted)2021-10-13Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 600 MHz, D2O, predicted)2021-10-13Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 600 MHz, D2O, predicted)2021-10-13Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 700 MHz, D2O, predicted)2021-10-13Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 700 MHz, D2O, predicted)2021-10-13Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 800 MHz, D2O, predicted)2021-10-13Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 800 MHz, D2O, predicted)2021-10-13Wishart LabView Spectrum
Predicted 1D NMR13C NMR Spectrum (1D, 900 MHz, D2O, predicted)2021-10-13Wishart LabView Spectrum
Predicted 1D NMR1H NMR Spectrum (1D, 900 MHz, D2O, predicted)2021-10-13Wishart LabView Spectrum
Biological Properties
Cellular LocationsNot Available
Biospecimen Locations
  • Blood
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodDetected but not QuantifiedNot QuantifiedNot SpecifiedNot SpecifiedNormal details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDDB03516
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider IDNot Available
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem Compound43157
PDB IDNot Available
ChEBI IDNot Available
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Barupal DK, Fiehn O: Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect. 2019 Sep;127(9):97008. doi: 10.1289/EHP4713. Epub 2019 Sep 26. [PubMed:31557052 ]